{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:15:50Z","timestamp":1793106950587,"version":"4.5.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Italian Ministry of Health","award":["GR-2013-02357959"],"award-info":[{"award-number":["GR-2013-02357959"]}]},{"DOI":"10.13039\/501100003407","name":"MIUR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.tem.2019.11.006","type":"journal-article","created":{"date-parts":[[2019,12,14]],"date-time":"2019-12-14T00:11:06Z","timestamp":1576282266000},"page":"205-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Mineralocorticoid Receptors in Metabolic Syndrome: From Physiology to Disease"],"prefix":"10.1016","volume":"31","author":[{"given":"Alessandra","family":"Feraco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Marzolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Scuteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Armani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Caprio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2019.11.006_bib1","doi-asserted-by":"crossref","first-page":"E1032","DOI":"10.3390\/ijms18051032","article-title":"Aldosterone and mineralocorticoid receptors-physiology and pathophysiology","volume":"18","author":"Funder","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2019.11.006_bib2","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1096\/fj.13-245415","article-title":"Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high-fat-diet-fed mice","volume":"28","author":"Armani","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.tem.2019.11.006_bib3","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","article-title":"Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines","volume":"117","author":"Guo","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.tem.2019.11.006_bib4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/cvr\/cvp191","article-title":"Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice","volume":"84","author":"Hirata","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tem.2019.11.006_bib5","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/HYPERTENSIONAHA.118.11339","article-title":"Epithelial sodium channel in aldosterone-induced endothelium stiffness and aortic dysfunction","volume":"72","author":"Jia","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2019.11.006_bib6","doi-asserted-by":"crossref","first-page":"e000018","DOI":"10.1161\/JAHA.112.000018","article-title":"Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism","volume":"2","author":"McGraw","year":"2013","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.tem.2019.11.006_bib7","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1093\/eurheartj\/eht095","article-title":"Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity","volume":"34","author":"Schafer","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.tem.2019.11.006_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/HYPERTENSIONAHA.114.04981","article-title":"Adipocyte mineralocorticoid receptor activation leads to metabolic syndrome and induction of prostaglandin D2 synthase","volume":"66","author":"Urbanet","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2019.11.006_bib9","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.tem.2009.05.006","article-title":"Mineralocorticoid receptors in the metabolic syndrome","volume":"20","author":"Zennaro","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tem.2019.11.006_bib10","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1210\/jc.2005-1733","article-title":"Prevalence and characteristics of the metabolic syndrome in primary aldosteronism","volume":"91","author":"Fallo","year":"2006","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2019.11.006_bib11","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/j.2040-4603.2017.tb00777.x","article-title":"Impact of adrenal steroids on regulation of adipose tissue","volume":"7","author":"Infante","year":"2017","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.tem.2019.11.006_bib12","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.118.033597","article-title":"Primary aldosteronism","volume":"138","author":"Byrd","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.tem.2019.11.006_bib13","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1210\/jc.2006-0736","article-title":"Insulin sensitivity in patients with primary aldosteronism: a follow-up study","volume":"91","author":"Catena","year":"2006","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2019.11.006_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/hr.2015.129","article-title":"Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism","volume":"39","author":"Karashima","year":"2016","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.tem.2019.11.006_bib15","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/nm.2891","article-title":"Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors","volume":"18","author":"McCurley","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.tem.2019.11.006_bib16","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1096\/fj.09-147926","article-title":"The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure","volume":"24","author":"Nguyen Dinh Cat","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.tem.2019.11.006_bib17","doi-asserted-by":"crossref","first-page":"E96","DOI":"10.3390\/biom8030096","article-title":"Mineralocorticoid receptor and aldosterone-related biomarkers of end-organ damage in cardiometabolic disease","volume":"8","author":"Gorini","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.tem.2019.11.006_bib18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.mce.2011.06.014","article-title":"Mineralocorticoid receptors in vascular function and disease","volume":"350","author":"McCurley","year":"2012","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.tem.2019.11.006_bib19","doi-asserted-by":"crossref","first-page":"e88942","DOI":"10.1172\/jci.insight.88942","article-title":"Vascular mineralocorticoid receptor regulates microRNA-155 to promote vasoconstriction and rising blood pressure with aging","volume":"1","author":"DuPont","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.tem.2019.11.006_bib20","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/HYPERTENSIONAHA.115.06172","article-title":"Endothelial mineralocorticoid receptors differentially contribute to coronary and mesenteric vascular function without modulating blood pressure","volume":"66","author":"Mueller","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2019.11.006_bib21","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1161\/ATVBAHA.111.229070","article-title":"Aldosterone regulates vascular gene transcription via oxidative stress-dependent and -independent pathways","volume":"31","author":"Newfell","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tem.2019.11.006_bib22","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1096\/fj.201800391RR","article-title":"Corticosteroid receptors adopt distinct cyclical transcriptional signatures","volume":"32","author":"Le Billan","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.tem.2019.11.006_bib23","doi-asserted-by":"crossref","first-page":"T107","DOI":"10.1530\/JOE-16-0659","article-title":"30 Years of the mineralocorticoid receptor: nongenomic effects via the mineralocorticoid receptor","volume":"234","author":"Ruhs","year":"2017","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.tem.2019.11.006_bib24","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/01.HYP.0000154365.30593.d3","article-title":"Aldosterone activates vascular p38MAP kinase and NADPH oxidase via c-Src","volume":"45","author":"Callera","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2019.11.006_bib25","doi-asserted-by":"crossref","first-page":"7665","DOI":"10.1074\/jbc.M809460200","article-title":"Aldosterone increases oxidant stress to impair guanylyl cyclase activity by cysteinyl thiol oxidation in vascular smooth muscle cells","volume":"284","author":"Maron","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.tem.2019.11.006_bib26","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/1440-1681.12125","article-title":"Direct contribution of vascular mineralocorticoid receptors to blood pressure regulation","volume":"40","author":"Barrett","year":"2013","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.tem.2019.11.006_bib27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/01.HYP.0000226054.53527.bb","article-title":"Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity","volume":"48","author":"Nagata","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2019.11.006_bib28","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/CIRCRESAHA.108.174235","article-title":"Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion","volume":"102","author":"Caprio","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.tem.2019.11.006_bib29","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1291\/hypres.31.1811","article-title":"Aldosterone enhances ligand-stimulated nitric oxide production in endothelial cells","volume":"31","author":"Mutoh","year":"2008","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.tem.2019.11.006_bib30","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/FJC.0b013e3181bfb00d","article-title":"Nitric oxide-mediated dilation of arterioles to intraluminal administration of aldosterone","volume":"54","author":"Heylen","year":"2009","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"key":"10.1016\/j.tem.2019.11.006_bib31","first-page":"3528","article-title":"Short term cardiovascular effects of aldosterone in healthy male volunteers","volume":"84","author":"Schmidt","year":"1999","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2019.11.006_bib32","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1042\/cs1030425","article-title":"Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy","volume":"103","author":"Farquharson","year":"2002","journal-title":"Clin. Sci. (Lond)"},{"key":"10.1016\/j.tem.2019.11.006_bib33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0021-9150(02)00363-5","article-title":"Aldosterone induces contraction of the resistance arteries in man","volume":"166","author":"Romagni","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tem.2019.11.006_bib34","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/HYPERTENSIONAHA.107.088955","article-title":"Influence of acute and chronic mineralocorticoid excess on endothelial function in healthy men","volume":"50","author":"Nietlispach","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2019.11.006_bib35","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s13075-016-1157-0","article-title":"Glucocorticoids and endothelial function in inflammatory diseases: focus on rheumatoid arthritis","volume":"18","author":"Verhoeven","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.tem.2019.11.006_bib36","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/HJH.0b013e328347da54","article-title":"Knockout of the vascular endothelial glucocorticoid receptor abrogates dexamethasone-induced hypertension","volume":"29","author":"Goodwin","year":"2011","journal-title":"J.\u00a0Hypertens"},{"key":"10.1016\/j.tem.2019.11.006_bib37","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.exger.2015.11.017","article-title":"Acute effect of mineralocorticoid receptor antagonism on vascular function in healthy older adults","volume":"73","author":"Hwang","year":"2016","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.tem.2019.11.006_bib38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/ajh\/hpy158","article-title":"Vascular mineralocorticoid receptor: evolutionary mediator of wound healing turned harmful by our modern lifestyle","volume":"32","author":"Biwer","year":"2019","journal-title":"Am. J. Hypertens"},{"key":"10.1016\/j.tem.2019.11.006_bib39","first-page":"97","article-title":"The endothelial mineralocorticoid receptor: mediator of the switch from vascular health to disease","volume":"26","author":"Davel","year":"2017","journal-title":"Curr. Opin. Nephrol. Hypertens"},{"key":"10.1016\/j.tem.2019.11.006_bib40","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.numecd.2015.01.002","article-title":"Abdominal obesity is associated with arterial stiffness in middle-aged adults","volume":"25","author":"Strasser","year":"2015","journal-title":"Nutr. Metab Cardiovasc. Dis."},{"key":"10.1016\/j.tem.2019.11.006_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2015.11.083","article-title":"Arterial stiffness, atherosclerosis and cardiovascular risk: pathophysiologic mechanisms and emerging clinical indications","volume":"77","author":"Palombo","year":"2016","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.tem.2019.11.006_bib42","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1161\/CIRCRESAHA.115.308269","article-title":"Endothelial mineralocorticoid receptor mediates diet-induced aortic stiffness in females","volume":"118","author":"Jia","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.tem.2019.11.006_bib43","first-page":"706","article-title":"Effects of aldosterone on human atherosclerosis: plasma aldosterone and progression of carotid plaque","volume":"28","author":"de Rita","year":"2012","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.tem.2019.11.006_bib44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijcard.2017.01.013","article-title":"Essential role of ICAM-1 in aldosterone-induced atherosclerosis","volume":"232","author":"Marzolla","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.tem.2019.11.006_bib45","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","article-title":"Mechanisms of plaque formation and rupture","volume":"114","author":"Bentzon","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.tem.2019.11.006_bib46","first-page":"139","article-title":"Induction of atherosclerotic plaques through activation of mineralocorticoid receptors in apolipoprotein E-deficient mice","volume":"26","author":"Marzolla","year":"2018","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.tem.2019.11.006_bib47","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/00005344-200306000-00019","article-title":"Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient mice","volume":"41","author":"Keidar","year":"2003","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"key":"10.1016\/j.tem.2019.11.006_bib48","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/FJC.0b013e31826f5535","article-title":"Eplerenone reduced lesion size in early but not advanced atherosclerosis in apolipoprotein E-deficient mice","volume":"60","author":"Raz-Pasteur","year":"2012","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"key":"10.1016\/j.tem.2019.11.006_bib49","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/01.RES.0000159937.05502.d1","article-title":"Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells","volume":"96","author":"Jaffe","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.tem.2019.11.006_bib50","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/apha.12466","article-title":"Vascular smooth muscle cell in atherosclerosis","volume":"214","author":"Chistiakov","year":"2015","journal-title":"Acta Physiol. (Oxf)"},{"key":"10.1016\/j.tem.2019.11.006_bib51","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1172\/JCI40205","article-title":"Placental growth factor mediates aldosterone-dependent vascular injury in mice","volume":"120","author":"Jaffe","year":"2010","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.tem.2019.11.006_bib52","doi-asserted-by":"crossref","first-page":"17629","DOI":"10.1074\/jbc.271.30.17629","article-title":"The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis","volume":"271","author":"Clauss","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.tem.2019.11.006_bib53","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1210\/en.2010-0925","article-title":"11beta-hydroxysteroid dehydrogenase type 2 deficiency accelerates atherogenesis and causes proinflammatory changes in the endothelium in Apoe\u2212\/\u2212 mice","volume":"152","author":"Deuchar","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2019.11.006_bib54","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.101.6.594","article-title":"Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I\/angiotensin II conversion in patients with chronic heart failure","volume":"101","author":"Farquharson","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.tem.2019.11.006_bib55","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.amjcard.2004.03.015","article-title":"Effect of spironolactone on endothelial function in patients with congestive heart failure on conventional medical therapy","volume":"93","author":"Abiose","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.tem.2019.11.006_bib56","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/CS20130200","article-title":"Mineralocorticoid receptors modulate vascular endothelial function in human obesity","volume":"125","author":"Hwang","year":"2013","journal-title":"Clin. Sci. (Lond)"},{"key":"10.1016\/j.tem.2019.11.006_bib57","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2337\/db14-0670","article-title":"Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes","volume":"64","author":"Garg","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2019.11.006_bib58","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/1358863X15584753","article-title":"Mineralocorticoid exposure and receptor activity modulate microvascular endothelial function in African Americans with and without hypertension","volume":"20","author":"Mohandas","year":"2015","journal-title":"Vasc. Med."},{"key":"10.1016\/j.tem.2019.11.006_bib59","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1096\/fj.06-7970com","article-title":"Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis","volume":"21","author":"Caprio","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.tem.2019.11.006_bib60","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1210\/en.2010-0674","article-title":"Antiadipogenic effects of the mineralocorticoid receptor antagonist drospirenone: potential implications for the treatment of metabolic syndrome","volume":"152","author":"Caprio","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2019.11.006_bib61","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JME-15-0122","article-title":"Cellular mechanisms of MR regulation of adipose tissue physiology and pathophysiology","volume":"55","author":"Armani","year":"2015","journal-title":"J.\u00a0Mol. Endocrinol."},{"key":"10.1016\/j.tem.2019.11.006_bib62","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-18-0314","article-title":"Minor role of mature adipocyte mineralocorticoid receptor in high fat induced obesity","author":"Feraco","year":"2018","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.tem.2019.11.006_bib63","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1530\/JOE-18-0026","article-title":"Impact of MR on mature adipocytes in high-fat\/high-sucrose diet-induced obesity","volume":"239","author":"Hayakawa","year":"2018","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.tem.2019.11.006_bib64","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/10408363.2015.1041582","article-title":"Adipocyte size as a determinant of metabolic disease and adipose tissue dysfunction","volume":"52","author":"Laforest","year":"2015","journal-title":"Crit. Rev. Clin. Lab Sci."},{"key":"10.1016\/j.tem.2019.11.006_bib65","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1194\/jlr.R046441","article-title":"Improved methodologies for the study of adipose biology: insights gained and opportunities ahead","volume":"55","author":"Wang","year":"2014","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.tem.2019.11.006_bib66","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/labinvest.2010.170","article-title":"DNA binding-dependent glucocorticoid receptor activity promotes adipogenesis via Kruppel-like factor 15 gene expression","volume":"91","author":"Asada","year":"2011","journal-title":"Lab Invest."},{"key":"10.1016\/j.tem.2019.11.006_bib67","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/ijo.2014.6","article-title":"The glucocorticoid receptor, not the mineralocorticoid receptor, plays the dominant role in adipogenesis and adipokine production in human adipocytes","volume":"38","author":"Lee","year":"2014","journal-title":"Int. J. Obes. (Lond)"},{"key":"10.1016\/j.tem.2019.11.006_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/JOE-16-0121","article-title":"Adipocyte glucocorticoid receptor has a minor contribution in adipose tissue growth","volume":"230","author":"Desarzens","year":"2016","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.tem.2019.11.006_bib69","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1210\/en.2018-00118","article-title":"Glucocorticoid receptor signaling is not required for in vivo adipogenesis","volume":"159","author":"Bauerle","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2019.11.006_bib70","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1172\/JCI1915","article-title":"Hibernoma development in transgenic mice identifies brown adipose tissue as a novel target of aldosterone action","volume":"101","author":"Zennaro","year":"1998","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.tem.2019.11.006_bib71","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/j.2040-4603.2018.tb00046.x","article-title":"Adipose organ development and remodeling","volume":"8","author":"Cinti","year":"2018","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.tem.2019.11.006_bib72","doi-asserted-by":"crossref","first-page":"E640","DOI":"10.1152\/ajpendo.2001.280.4.E640","article-title":"Mineralocorticoid and glucocorticoid receptors inhibit UCP expression and function in brown adipocytes","volume":"280","author":"Viengchareun","year":"2001","journal-title":"Am. J. Physiol Endocrinol. Metab."},{"key":"10.1016\/j.tem.2019.11.006_bib73","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/dom.13539","article-title":"Mineralocorticoid antagonism enhances brown adipose tissue function in humans: a randomized placebo-controlled cross-over study","volume":"21","author":"Thuzar","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.tem.2019.11.006_bib74","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbrc.2011.06.126","article-title":"Sustained expression of lipocalin-type prostaglandin D synthase in the antisense direction positively regulates adipogenesis in cloned cultured preadipocytes","volume":"411","author":"Chowdhury","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tem.2019.11.006_bib75","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.2337\/db12-0015","article-title":"A new role for lipocalin prostaglandin d synthase in the regulation of brown adipose tissue substrate utilization","volume":"61","author":"Virtue","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2019.11.006_bib76","doi-asserted-by":"crossref","first-page":"154735","DOI":"10.1016\/j.cyto.2019.154735","article-title":"Leptin as a predictive marker for metabolic syndrome","volume":"121","author":"Ghadge","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.tem.2019.11.006_bib77","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1161\/CIRCULATIONAHA.115.018226","article-title":"Adipocyte-derived hormone leptin is a direct regulator of aldosterone secretion, which promotes endothelial dysfunction and cardiac fibrosis","volume":"132","author":"Huby","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.tem.2019.11.006_bib78","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/1573399810666140508121012","article-title":"Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes","volume":"10","author":"Wang","year":"2014","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.tem.2019.11.006_bib79","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jjcc.2013.11.006","article-title":"Adipokines: a link between obesity and cardiovascular disease","volume":"63","author":"Nakamura","year":"2014","journal-title":"J.\u00a0Cardiol."},{"key":"10.1016\/j.tem.2019.11.006_bib80","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI21625","article-title":"Increased oxidative stress in obesity and its impact on metabolic syndrome","volume":"114","author":"Furukawa","year":"2004","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.tem.2019.11.006_bib81","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1096\/fj.201601125RRR","article-title":"Molecular mechanisms underlying metabolic syndrome: the expanding role of the adipocyte","volume":"31","author":"Armani","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.tem.2019.11.006_bib82","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.2337\/db15-1627","article-title":"Adipocyte-specific mineralocorticoid receptor overexpression in mice is associated with metabolic syndrome and vascular dysfunction: role of redox-sensitive PKG-1 and Rho kinase","volume":"65","author":"Nguyen Dinh","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2019.11.006_bib83","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1515\/hmbci-2014-0048","article-title":"The role of perivascular adipose tissue in vasoconstriction, arterial stiffness, and aneurysm","volume":"21","author":"Villacorta","year":"2015","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"10.1016\/j.tem.2019.11.006_bib84","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/HYPERTENSIONAHA.118.11873","article-title":"MR (mineralocorticoid receptor) induces adipose tissue senescence and mitochondrial dysfunction leading to vascular dysfunction in obesity","volume":"73","author":"Lefranc","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2019.11.006_bib85","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/cvr\/cvx097","article-title":"The role of mineralocorticoid receptor signaling in the cross-talk between adipose tissue and the vascular wall","volume":"113","author":"Jia","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tem.2019.11.006_bib86","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cmet.2016.04.011","article-title":"Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk","volume":"23","author":"Stern","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2019.11.006_bib87","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41574-018-0009-1","article-title":"Targeting autophagy in obesity: from pathophysiology to management","volume":"14","author":"Zhang","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.tem.2019.11.006_bib88","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/obr.12584","article-title":"Human brown adipose tissue as a target for obesity management; beyond cold-induced thermogenesis","volume":"18","author":"Loh","year":"2017","journal-title":"Obes. Rev."},{"key":"10.1016\/j.tem.2019.11.006_bib89","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/dom.12224","article-title":"Effect of mineralocorticoid receptor antagonist on insulin resistance and endothelial function in obese subjects","volume":"16","author":"Garg","year":"2014","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.tem.2019.11.006_bib90","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1210\/jc.2018-00330","article-title":"Randomized, placebo-controlled trial to evaluate effects of eplerenone on metabolic and inflammatory indices in HIV","volume":"103","author":"Srinivasa","year":"2018","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2019.11.006_bib91","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41574-018-0118-x","article-title":"Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases","volume":"15","author":"Clemmensen","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.tem.2019.11.006_bib92","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1172\/JCI67803","article-title":"Recruited brown adipose tissue as an antiobesity agent in humans","volume":"123","author":"Yoneshiro","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.tem.2019.11.006_bib93","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijcard.2015.05.127","article-title":"Safety profile of mineralocorticoid receptor antagonists: spironolactone and eplerenone","volume":"200","author":"Lainscak","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.tem.2019.11.006_bib94","doi-asserted-by":"crossref","DOI":"10.1177\/2054358117698669","article-title":"Obesity and kidney\u00a0disease: hidden consequences of the epidemic","volume":"4","author":"Kovesdy","year":"2017","journal-title":"Can. J. Kidney Health Dis."},{"key":"10.1016\/j.tem.2019.11.006_bib95","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1093\/eurheartj\/ehw132","article-title":"A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and\/or chronic kidney disease","volume":"37","author":"Filippatos","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.tem.2019.11.006_bib96","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1111\/dom.13756","article-title":"Comment on \"mineralocorticoid antagonism enhances brown adipose tissue function in humans: a randomized placebo-controlled cross-over study\"","volume":"21","author":"Armani","year":"2019","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.tem.2019.11.006_bib97","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/FJC.0000000000000091","article-title":"Finerenone, a novel selective nonsteroidal mineralocorticoid receptor antagonist protects from rat cardiorenal injury","volume":"64","author":"Kolkhof","year":"2014","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"key":"10.1016\/j.tem.2019.11.006_bib98","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"Forstermann","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.tem.2019.11.006_bib99","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/01.RES.0000255894.25293.82","article-title":"Myosin phosphatase regulatory pathways: different functions or redundant functions?","volume":"100","author":"Lincoln","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.tem.2019.11.006_bib100","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1210\/endo.132.6.8504747","article-title":"Aldosterone stimulated differentiation of mouse 3T3-L1 cells into adipocytes","volume":"132","author":"Rondinone","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2019.11.006_bib101","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.steroids.2014.05.001","article-title":"Mineralocorticoid receptor in adipocytes and macrophages: a promising target to fight metabolic syndrome","volume":"91","author":"Marzolla","year":"2014","journal-title":"Steroids"},{"key":"10.1016\/j.tem.2019.11.006_bib102","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/ijo.2014.68","article-title":"Mineralocorticoid vs glucocorticoid receptors: solo players or team mates in the control of adipogenesis?","volume":"38","author":"Armani","year":"2014","journal-title":"Int. J. Obes. (Lond)"},{"key":"10.1016\/j.tem.2019.11.006_bib103","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/ijo.2016.13","article-title":"A novel combined glucocorticoid-mineralocorticoid receptor selective modulator markedly prevents weight gain and fat mass expansion in mice fed a high-fat diet","volume":"40","author":"Mammi","year":"2016","journal-title":"Int. J. Obes. (Lond)"},{"key":"10.1016\/j.tem.2019.11.006_bib104","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1089\/ars.2018.7626","article-title":"Autophagy in adipose tissue physiology and pathophysiology","volume":"31","author":"Ferhat","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.tem.2019.11.006_bib105","first-page":"3329","article-title":"Autophagy regulates adipose mass and differentiation in mice","volume":"119","author":"Singh","year":"2009","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.tem.2019.11.006_bib106","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1091\/mbc.e15-10-0749","article-title":"Cell biology of fat storage","volume":"27","author":"Cohen","year":"2016","journal-title":"Mol. Biol. Cell"}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276019302280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276019302280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:39:10Z","timestamp":1760906350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276019302280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":106,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1043276019302280"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2019.11.006","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mineralocorticoid Receptors in Metabolic Syndrome: From Physiology to Disease","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2019.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}